|Articles|July 1, 2019

BioPharm International

  • BioPharm International-07-01-2019
  • Volume 32
  • Issue 7

BioPharm International, July 2019 Issue (PDF)

Click the title above to open the BioPharm International July 2019 issue in an interactive PDF format.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 6 years ago

FDA Revamps Biosimilar Quality Requirements

over 6 years ago

Playbooks Are Not Just Child’s Play

over 6 years ago

Applying QbD to Upstream Processing

over 6 years ago

A Biologics Partisan Divide

over 6 years ago

Analysis of Residual Impurities in Continuous Manufacturing

over 6 years ago

Gene Therapies Propel Outsourcing Investment

over 6 years ago

Removing Gaps in Data Integrity

over 6 years ago

Catching Up Downstream

over 6 years ago

Design Considerations for a Commercial Cell and Gene Therapy Facility

over 6 years ago

Catalytic Site Analysis and Characterization of a Solvent-Tolerant Aldo-Keto Reductase

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!